Results 171 to 180 of about 21,171,014 (388)

Association of physical activity with bleeding events and safety in patients with haemophilia A starting emicizumab prophylaxis: an interim analysis of the TSUBASA study [PDF]

, 2023
Keiji Nogami, Teruhisa Fujii, Akihiro Sawada, Azusa Nagao, Chiai Nagae, Masanori Nojima, Nobuaki Suzuki, Daisuke Nosaka, Tomomi Shimura, Yoshimasa Sugao, Kagehiro Amano   +10 more
openalex   +1 more source

Integration of Efanesoctocog Alfa in Clinical Practice for Children, Adolescents, and Young Adults With Severe Haemophilia A

Haemophilia, EarlyView.
ABSTRACT Introduction Efanesoctocog alfa is a novel, “ultra‐extended half‐life” FVIII concentrate for bleed treatment and prevention in haemophilia A. Clinical trials excluded individuals with active or prior FVIII inhibitors, those on emicizumab, and previously untreated patients (PUPs).
Debbie Jiang, Natalie Johnston, Daniel Echelman, Stacy E. Croteau   +3 more
wiley   +1 more source

Localised intramesenteric haemorrhage--a recognisable syndrome in haemophilia? [PDF]

, 1979
M I Adelman, P. Gishen, Paul A. Dubbins, R.S. Mibashan   +3 more
openalex   +1 more source

Validating the Online Self‐Administered Bleeding Assessment Tool (Self‐BAT) as a Screening Tool for Bleeding Disorders

Haemophilia, EarlyView.
Veronica DeYoung, Julie Grabell, Wilma Hopman, Megan Chaigneau, Maria Avgeropoulos, Paula James   +5 more
wiley   +1 more source

Evaluation of the Burden of Bone Fractures in People Living With Haemophilia: A Registry‐Based Matched Cohort Study

Haemophilia, EarlyView.
ABSTRACT Background Bone diseases, such as low bone mineral density and osteoporosis is an emerging concern in people with haemophilia (PWH). As a consequence, PWH might experience fractures more frequently than the general population. Our primary aim was to compare the incidence of bone fractures in PWH and controls without bleeding disorders.
Federico Germini, Arun Keepanasseril, Quazi Ibrahim, Emma Iserman, Alfonso Iorio, Chatree Chai‐Adisaksopha, Davide Matino   +6 more
wiley   +1 more source

Development of decision-making considerations to support equitable patient selection in paediatric haemophilia trials [PDF]

, 2022
Anne Fu, Karen Strike, Korinne Hamilton, Linda Waterhouse, Kay Decker, Theresa M. Almonte, Anthony K.C. Chan   +6 more
openalex   +1 more source

International Practices in Managing Preconception, Pregnancy and Childbirth in Women With Glanzmann Thrombasthenia: A Survey From the European Association of Haemophilia and Allied Disorders (EAHAD)

Haemophilia, EarlyView.
ABSTRACT Background Glanzmann thrombasthenia (GT) is an inherited platelet disorder resulting in severely reduced platelet aggregation and increased bleeding tendency. Pregnancy and childbirth in women with GT present significant challenges for both mother and child.
Karlijn H. G. Rutten, Roger E. G. Schutgens, Roseline d'Oiron, Mathieu Fiore, Giancarlo Castaman, Keith Gomez, Mary Mathias, Michelle Lavin, Petra Elfvinge, Rezan Abdul Kadir, Karin P. M. van Galen, the Glanzmann Thrombasthenia and Women and Girls with Bleeding Disorders Working Groups of the EAHAD   +11 more
wiley   +1 more source

Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies [PDF]

, 2000
Acquired hemophilia, caused by autoantibodies against coagulation factor VIII, is usually treated with steroids, cyclophosphamide, intravenous gammaglobulins and sporadically other drugs.
Baele, Gaston, Derom, Eric, Petrovic, Mirko   +2 more
core  

PB0679 Clinical Characteristics and Disease Outcomes in Previously Treated Patients with Haemophilia: Results from a Real-World Study in Europe and United States

, 2023
Jennifer M. Mellor, K. Golden, S. Olsen, Nick Ball, Jade Garratt-Wheeldon   +4 more
openalex   +1 more source

In‐hospital management of persons with haemophilia and COVID‐19: Practical guidance [PDF]

, 2020
Cédric Hermans, Catherine Lambert, Amaury Sogorb, Xavier Wittebole, Leïla Belkhir, Jean Cyr Yombi   +5 more
openalex   +1 more source